Insulet PODD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $302.8M+22.5% | $247.1M+0.4% | $246.2M+4.3% | $236.1M-41.3% | $402.2M-3.8% | ||
| $94.9M+5.0% | $90.4M+3.3% | $87.5M+0.8% | $86.8M+3.7% | $83.7M+3.6% | ||
| $65.8M+4.9% | $62.7M+0.5% | $62.4M-2.2% | $63.8M-13.0% | $73.3M+5.8% | ||
| $66.2M+6.4% | $62.2M— | —— | —— | —— | ||
| $4.4M-29.0% | $6.2M-15.1% | $7.3M-9.9% | $8.1M+3.8% | $7.8M+6.8% | ||
| —— | —— | $4.3M+2.4% | $4.2M+31.3% | $3.2M+1,167% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $61.3M-25.0% | $81.7M+34.8% | $60.6M+60.3% | $37.8M+10.2% | $34.3M+56.6% | ||
| $2.8M-60.0% | $7M+40.0% | $5M+16.3% | $4.3M-50.0% | $8.6M+75.5% | ||
| -$84.4M+31.9% | -$123.9M0.0% | -$123.9M0.0% | -$123.9M-214% | -$39.5M— | ||
| $619.3M+8.8% | $569.3M+6.7% | $533.5M+3.4% | $516.1M+27.0% | $406.4M-5.5% | ||
| $203.6M+6.3% | $191.6M+74.0% | $110.1M-1.0% | $111.2M-3.4% | $115.1M-7.8% | ||
| —— | $3.2M+33.3% | $2.4M+50.0% | $1.6M+100% | $800K— | ||
| -$234.8M-5.4% | -$222.7M-61.5% | -$137.9M-1.2% | -$136.2M+1.2% | -$137.8M+5.7% | ||
| $359.6M+503% | $59.6M0.0% | $59.6M+98.0% | $30.1M— | —— | ||
| —— | —— | —— | —— | $440.7M— | ||
| $888.3M-15.6% | $1.05B0.0% | $1.05B+94.3% | $541.5M+230% | $163.9M— | ||
| $16.9M-11.1% | $19M+7.3% | $17.7M+27.3% | $13.9M+184% | $4.9M-40.2% | ||
| $20.4M-21.2% | $25.9M+0.8% | $25.7M+5.3% | $24.4M+2.5% | $23.8M+213% | ||
| -$1.19B-100% | -$595.3M-9.5% | -$543.6M-514% | -$88.5M— | —— | ||
| —— | —— | —— | $9.3M+1,960% | -$500K+92.6% | ||
| -$802.7M-238% | -$237.3M-63.4% | -$145.2M-148% | $300.6M-43.5% | $531.9M+113% | ||
| $4.4M-29.0% | $6.2M-15.1% | $7.3M-9.9% | $8.1M+3.8% | $7.8M+6.8% | ||
| —— | —— | —— | —— | —— | ||
| $61.3M-25.0% | $81.7M+34.8% | $60.6M+60.3% | $37.8M+10.2% | $34.3M+56.6% | ||
| —— | —— | $4.3M+2.4% | $4.2M+31.3% | $3.2M+1,167% | ||
| —— | $5.4M+35.0% | $4M+53.8% | $2.6M+117% | $1.2M+700% | ||
| —— | $3.2M+33.3% | $2.4M+50.0% | $1.6M+100% | $800K— | ||
| $19.3M+0.5% | $19.2M+20.8% | $15.9M+24.2% | $12.8M+20.8% | $10.6M+16.5% | ||
| —— | —— | —— | —— | $440.7M— | ||
| $141.5M-14.0% | $164.6M0.0% | $164.6M+117% | $75.7M— | —— | ||
| $888.3M-15.6% | $1.05B0.0% | $1.05B+94.3% | $541.5M+230% | $163.9M— | ||
| $49M-21.5% | $62.4M-3.1% | $64.4M+8.8% | $59.2M+22.8% | $48.2M+38.5% | ||
| $34.5M-30.9% | $49.9M-19.9% | $62.3M-2.2% | $63.7M+4.6% | $60.9M+33.8% | ||
| $415.7M+10.1% | $377.7M-10.8% | $423.4M+4.6% | $404.9M+39.0% | $291.3M-4.6% | ||
| $415.7M+10.1% | $377.7M-10.8% | $423.4M+4.6% | $404.9M+39.0% | $291.3M-4.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Insulet generate?
- Insulet (PODD) generated $619.3M in operating cash flow over the trailing twelve months.
- What is Insulet's free cash flow?
- After $203.6M of capital expenditures, Insulet's free cash flow was $415.7M over the trailing twelve months, up 42.7% year over year.
- Where does Insulet's cash flow data come from?
- Every line is extracted from Insulet's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
